Cellectar Biosciences, Inc. logo

CLRBCellectar Biosciences, Inc.

CLRB Stock Price, Valuation & Chart | Cellectar Biosciences, Inc.

Compare

CLRB Historical price chart

CLRB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization19.42M
PE Ratio-0.36
EPS-6.66
Trading Volume48.76K
Today's High/Low2.5/2.42
Dividend Yield0.00
52 Week High/Low6.52/2.2
Shares Outstanding7.99M
CLRB Financial Statement
CLRB Analyst ratings
CLRB Analysis & performance metrics

CLRB Company profile

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead…

CLRB Management team

Management
Jarrod LongcorCOO
Chief Operating Officer
James V. CarusoCEO
President, Chief Executive Officer & Director
Chad J. Kolean CPACFO
Vice President, Chief Financial Officer & Secretary
Total 3 executives

CLRB Frequently asked questions

What is Cellectar Biosciences, Inc. (CLRB) Stock Price?

Current stock price of Cellectar Biosciences, Inc. (CLRB) stock is $2.430. The stock price is -1.22% lower in the session. The intraday range can be seen from this page. Volume of Cellectar Biosciences, Inc. (CLRB) stock is 48.76K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Cellectar Biosciences, Inc. (CLRB) stock price going up or down today?

The stock price of Cellectar Biosciences, Inc. (CLRB) can change with earnings, company news, and overall market sentiment. Cellectar Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cellectar Biosciences, Inc. stock expensive at its current price?

Whether Cellectar Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CLRB on this page is -0.36. EPS on this page is -6.66. Compare those figures with peers and growth expectations before deciding if the current Cellectar Biosciences, Inc. price is justified.

How has the stock price of Cellectar Biosciences, Inc. (CLRB) performed historically?

Historical performance for Cellectar Biosciences, Inc. (CLRB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CLRB reacted to past earnings and market events.

Should I buy Cellectar Biosciences, Inc. (CLRB) stock, at this price?

Buying Cellectar Biosciences, Inc. (CLRB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.